Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” NASDAQ: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced that it will participate at the following upcoming virtual investor conferences: Cowen 41st Annual Health Care Conference Date and Time: March 2, 2021 at 2:10 p.m. Eastern Time
February 23, 2021
· 1 min read